Related Experiment Video
Updated: Aug 11, 2026

A Caenorhabditis elegans Model System for Amylopathy Study
Published on: May 17, 2013
The chick embryo appears as a natural model for research in beta-amyloid precursor protein processing
J A Carrodeguas1, A Rodolosse, M V Garza
1Laboratory of Neurobiology, Department of Anatomy, Embryology and Genetics, University of Zaragoza, Spain.
Insights
The chick embryo processes amyloid beta, a peptide linked to Alzheimer's disease. This finding suggests the chick embryo is a valuable model for studying Alzheimer's disease mechanisms and potential drug development.
Area of Science:
- Neuroscience
- Developmental Biology
- Biochemistry
Background:
- Alzheimer's disease is characterized by amyloid beta peptide accumulation.
- Mammalian models like rats and mice have distinct amyloid beta sequences compared to humans.
- Understanding amyloid beta processing in early development is crucial.
Purpose of the Study:
- To investigate the presence and function of amyloid beta production and degradation machinery in the chick embryo.
- To compare chick embryo amyloid beta sequences and expression patterns with human and other mammalian models.
- To evaluate the chick embryo as a model for Alzheimer's disease research.
Main Methods:
- Cloning of principal beta-amyloid precursor protein isoforms in the chick embryo.
- Sequence homology analysis comparing chick, human, and mammalian sequences.
- Gene expression analysis of proteases involved in amyloid beta production and degradation.
- Assessment of amyloid beta peptide variants (Abeta40 and Abeta42) produced during embryogenesis.
Main Results:
- Chick embryo beta-amyloid precursor protein isoforms are highly homologous to human sequences, differing from rat and mouse.
- Ubiquitous expression of beta-amyloid precursor protein isoforms was observed, with predominant expression of APP695 in the nervous system.
- Chick embryos express key genes for amyloid beta production (BACE-1, BACE-2, presenilin-1, presenilin-2, nicastrin) and degradation (neprilysin, ADAM-17).
- Amyloid beta 42 appears to be the major amyloid beta peptide produced during chick embryogenesis.
Conclusions:
- The chick embryo possesses the complete machinery for amyloid beta peptide production and degradation.
- The chick embryo serves as a suitable natural model for studying the cell biology and developmental roles of beta-amyloid precursor protein.
- The chick embryo presents a potential assay system for developing drugs targeting beta-amyloid precursor protein processing.
Abstract:
This study reveals that the chick embryo has active the machinery for the production and degradation of the amyloid beta peptide characteristic of Alzheimer's disease. We cloned the principal beta-amyloid precursor protein isoforms in the chick embryo and observed that they are highly homologous to the human sequences and identical at the C-terminal sequence, including the amyloid beta domain. Mammals such as rat or mouse, more commonly used as animal models of human diseases, have a distinct amyloid beta sequence. The distribution of beta-amyloid precursor protein isoforms in the chick embryo revealed that, as in humans, their expression is ubiquitous and the prototype beta-amyloid precursor protein-695 predominated in the nervous system. We also found that the chick embryo expresses the genes for the main proteolytic proteases implicated in the production of amyloid beta, including BACE-1, BACE-2, presenilin-1, presenilin-2 and nicastrin, as well as the amyloid beta-degrading enzyme neprilysin, or ADAM-17, a protease implicated in the non-amyloidogenic processing of beta-amyloid precursor protein. We have also found that between amyloid beta40 and amyloid beta42, this latter seems to be the major amyloid beta peptide produced during chick embryogenesis. The chick embryo appears as a suitable natural model to study cell biology and developmental function of beta-amyloid precursor protein and a potential assay system for drugs that regulate beta-amyloid precursor protein processing.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding Quality Check in the RER

